The Advocate Article RatingFederal appeals panel asks skeptical questions about FDA approval of abortion drug
- Bias Rating
-18% Somewhat Liberal
- Reliability
N/AN/A
- Policy Leaning
-8% Center
- Politician Portrayal
44% Negative
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
N/A
- Liberal
- Conservative
| Sentence | Sentiment | Bias |
|---|---|---|
| "A group of anti-abortion doctors called the Alliance for Hippocratic Medicine challenged the FDA's approval of the drug two decades ago, and several agency steps in 2016 that expanded access to it." | Positive | 14% Conservative |
| "Much of Wednesday's hearing at the U.S. Fifth Circuit Court of Appeals focused on whether a group of anti-abortion doctors has legal standing to challenge the FDA's approval in 2000 and subsequent expanded access for mifepristone, one of two drugs used commonly in chemical abortions." | Positive | 8% Conservative |
| "All three judges questioned the regulatory basis for the drug's approval and expanded access, while steering clear of a national debate over abortion itself, following the U.S. Supreme Court's ruling last June removing a constitutional right to the procedure." | Negative | -14% Liberal |
| "The panel was hearing an appeal to a ruling by a Texas jurist, Matthew J. Kacsmaryk, also a Trump nominee, who said approval of the drug should be overturned." | Negative | -18% Liberal |
| "My whole point is the status has changed dramatically, added Judge James C. Ho of Texas, who like Wilson was nominated to the bench by former President Donald Trump." | Negative | -28% Liberal |
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
57% : A group of anti-abortion doctors called the Alliance for Hippocratic Medicine challenged the FDA's approval of the drug two decades ago, and several agency steps in 2016 that expanded access to it.54% : Much of Wednesday's hearing at the U.S. Fifth Circuit Court of Appeals focused on whether a group of anti-abortion doctors has legal standing to challenge the FDA's approval in 2000 and subsequent expanded access for mifepristone, one of two drugs used commonly in chemical abortions.
43% : All three judges questioned the regulatory basis for the drug's approval and expanded access, while steering clear of a national debate over abortion itself, following the U.S. Supreme Court's ruling last June removing a constitutional right to the procedure.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.